Confirmation of involvement of new variants at CDKN2A/B in pediatric acute lymphoblastic leukemia susceptibility in the Spanish population

por Gutierrez-Camino, Angela, Martin-Guerrero, Idoia, Garcia de Andoin, Nagore, Sastre, Ana, Carbone Bañeres, Ana, Astigarraga, Itziar, Navajas, Aurora, Garcia-Orad, Africa
Publicado 2017

MEDB-65. Molecular subclassification of a national cohort of pediatric medulloblastoma based on methylation profile

por Alaña, Lide, Martin-Guerrero, Idoia, Navajas, Aurora, Zaldumbide, Laura, Mosteiro, Lorena, Schwalbe, Edward C, Hicks, Debbie, Clifford, Steven C, García-Ariza, Miguel
Publicado 2022

Pharmacogenetics of MicroRNAs and MicroRNAs Biogenesis Machinery in Pediatric Acute Lymphoblastic Leukemia

por López-López, Elixabet, Gutiérrez-Camino, Ángela, Piñán, Maria Ángeles, Sánchez-Toledo, José, Uriz, Jose Javier, Ballesteros, Javier, García-Miguel, Purificación, Navajas, Aurora, García-Orad, África
Publicado 2014

Involvement of SNPs in miR-3117 and miR-3689d2 in childhood acute lymphoblastic leukemia risk

por Gutierrez-Camino, Angela, Martin-Guerrero, Idoia, Dolzan, Vita, Jazbec, Janez, Carbone-Bañeres, Ana, Garcia de Andoin, Nagore, Sastre, Ana, Astigarraga, Itziar, Navajas, Aurora, Garcia-Orad, Africa
Publicado 2018

Relapse patterns and outcome after relapse in standard risk medulloblastoma: a report from the HIT-SIOP-PNET4 study

por Sabel, Magnus, Fleischhack, Gudrun, Tippelt, Stephan, Gustafsson, Göran, Doz, François, Kortmann, Rolf, Massimino, Maura, Navajas, Aurora, von Hoff, Katja, Rutkowski, Stefan, Warmuth-Metz, Monika, Clifford, Steven C., Pietsch, Torsten, Pizer, Barry, Lannering, Birgitta
Publicado 2016

EMBR-25. GENOME-WIDE GENETIC AND EPIGENETIC ASSESSMENT OF GROUP 4 MEDULLOBLASTOMA FOR IMPROVED, BIOMARKER DRIVEN, PROGNOSTICATION AND RISK-STRATIFICATION

por Goddard, Jack, Castle, Jemma, Southworth, Emily, Crosier, Stephen, Martin-Guerrero, Idoia, Garcia-Ariza, Miguel, Navajas, Aurora, Bourdeaut, Franck, Dufour, Christelle, Goschzik, Tobias, Pietsch, Torsten, Williamson, Dan, Bailey, Simon, Schwalbe, Ed, Clifford, Steven, Hicks, Debbie
Publicado 2021

MEDB-71. Molecular characterisation of group 4 medulloblastoma improves risk-stratification and its biological understanding

por Goddard, Jack, Castle, Jemma, Southworth, Emily, Fletcher, Anya, Crosier, Stephen, Martin-Guerrero, Idoia, Garcia-Ariza, Miguel, Navajas, Aurora, Masliah-Planchon, Julien, Bourdeaut, Franck, Dufour, Christelle, Goschizk, Tobias, Pietsch, Torsten, Richardson, Stacey, Hill, Rebecca M, Williamson, Daniel, Bailey, Simon, Schwalbe, Edward C, Clifford, Steven C, Hicks, Debbie
Publicado 2022

Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification

por Goddard, Jack, Castle, Jemma, Southworth, Emily, Fletcher, Anya, Crosier, Stephen, Martin-Guerrero, Idoia, García-Ariza, Miguel, Navajas, Aurora, Masliah-Planchon, Julien, Bourdeaut, Franck, Dufour, Christelle, Ayrault, Olivier, Goschzik, Tobias, Pietsch, Torsten, Sill, Martin, Pfister, Stefan M., Rutkowski, Stefan, Richardson, Stacey, Hill, Rebecca M., Williamson, Daniel, Bailey, Simon, Schwalbe, Edward C., Clifford, Steven C., Hicks, Debbie
Publicado 2023